These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The use of methotrexate in polymyalgia rheumatica.
    Author: Feinberg HL, Sherman JD, Schrepferman CG, Dietzen CJ, Feinberg GD.
    Journal: J Rheumatol; 1996 Sep; 23(9):1550-2. PubMed ID: 8877923.
    Abstract:
    OBJECTIVE: To examine the efficacy and steroid sparing potential of methotrexate (MTX) in the treatment of polymyalgia rheumatica (PMR) without giant cell arteritis. METHODS: 43 patients with PMR were treated with MTX 7.5 mg/wk for 3 months. This dose was raised to 10 and finally 12.5 mg/wk MTX if the desired response was not obtained. RESULTS: No patient benefitted clinically or statistically from treatment with MTX. CONCLUSION: MTX is of no benefit in the treatment of PMR.
    [Abstract] [Full Text] [Related] [New Search]